Logo image of LFVN

LIFEVANTAGE CORP (LFVN) Stock Fundamental Analysis

USA - NASDAQ:LFVN - US53222K2050 - Common Stock

10.68 USD
-0.45 (-4.04%)
Last: 9/15/2025, 8:13:30 PM
10.68 USD
0 (0%)
After Hours: 9/15/2025, 8:13:30 PM
Fundamental Rating

7

Overall LFVN gets a fundamental rating of 7 out of 10. We evaluated LFVN against 36 industry peers in the Personal Care Products industry. LFVN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. A decent growth rate in combination with a cheap valuation! Better keep an eye on LFVN. With these ratings, LFVN could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year LFVN was profitable.
LFVN had a positive operating cash flow in the past year.
LFVN had positive earnings in each of the past 5 years.
LFVN had a positive operating cash flow in each of the past 5 years.
LFVN Yearly Net Income VS EBIT VS OCF VS FCFLFVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

The Return On Assets of LFVN (13.63%) is better than 91.67% of its industry peers.
Looking at the Return On Equity, with a value of 28.30%, LFVN belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
The Return On Invested Capital of LFVN (20.12%) is better than 91.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LFVN is in line with the industry average of 12.97%.
The last Return On Invested Capital (20.12%) for LFVN is above the 3 year average (11.79%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.63%
ROE 28.3%
ROIC 20.12%
ROA(3y)7.43%
ROA(5y)8.61%
ROE(3y)15.61%
ROE(5y)18.34%
ROIC(3y)11.79%
ROIC(5y)14.42%
LFVN Yearly ROA, ROE, ROICLFVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200

1.3 Margins

LFVN has a better Profit Margin (4.29%) than 66.67% of its industry peers.
LFVN's Profit Margin has declined in the last couple of years.
LFVN has a Operating Margin (5.34%) which is in line with its industry peers.
LFVN's Operating Margin has declined in the last couple of years.
LFVN has a better Gross Margin (80.37%) than 97.22% of its industry peers.
In the last couple of years the Gross Margin of LFVN has remained more or less at the same level.
Industry RankSector Rank
OM 5.34%
PM (TTM) 4.29%
GM 80.37%
OM growth 3Y13.18%
OM growth 5Y-4.32%
PM growth 3Y41.89%
PM growth 5Y-2.77%
GM growth 3Y-0.48%
GM growth 5Y-0.82%
LFVN Yearly Profit, Operating, Gross MarginsLFVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LFVN is creating value.
Compared to 1 year ago, LFVN has less shares outstanding
LFVN has less shares outstanding than it did 5 years ago.
LFVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LFVN Yearly Shares OutstandingLFVN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
LFVN Yearly Total Debt VS Total AssetsLFVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

An Altman-Z score of 4.28 indicates that LFVN is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.28, LFVN is doing good in the industry, outperforming 69.44% of the companies in the same industry.
There is no outstanding debt for LFVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.28
ROIC/WACC2.31
WACC8.7%
LFVN Yearly LT Debt VS Equity VS FCFLFVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.3 Liquidity

LFVN has a Current Ratio of 1.87. This is a normal value and indicates that LFVN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.87, LFVN is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Quick Ratio of 1.11 indicates that LFVN should not have too much problems paying its short term obligations.
LFVN has a Quick ratio of 1.11. This is comparable to the rest of the industry: LFVN outperforms 47.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.11
LFVN Yearly Current Assets VS Current LiabilitesLFVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

5

3. Growth

3.1 Past

LFVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.48%, which is quite impressive.
Measured over the past years, LFVN shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.70% on average per year.
The Revenue has grown by 14.17% in the past year. This is quite good.
LFVN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.38% yearly.
EPS 1Y (TTM)34.48%
EPS 3Y23.91%
EPS 5Y-1.7%
EPS Q2Q%7.14%
Revenue 1Y (TTM)14.17%
Revenue growth 3Y3.45%
Revenue growth 5Y-0.38%
Sales Q2Q%12.64%

3.2 Future

The Earnings Per Share is expected to grow by 32.87% on average over the next years. This is a very strong growth
Based on estimates for the next years, LFVN will show a small growth in Revenue. The Revenue will grow by 2.08% on average per year.
EPS Next Y31.42%
EPS Next 2Y32.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.79%
Revenue Next 2Y2.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LFVN Yearly Revenue VS EstimatesLFVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
LFVN Yearly EPS VS EstimatesLFVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.69 indicates a correct valuation of LFVN.
Compared to the rest of the industry, the Price/Earnings ratio of LFVN indicates a rather cheap valuation: LFVN is cheaper than 86.11% of the companies listed in the same industry.
LFVN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.42, which indicates a very decent valuation of LFVN.
83.33% of the companies in the same industry are more expensive than LFVN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of LFVN to the average of the S&P500 Index (22.77), we can say LFVN is valued rather cheaply.
Industry RankSector Rank
PE 13.69
Fwd PE 10.42
LFVN Price Earnings VS Forward Price EarningsLFVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LFVN is valued a bit cheaper than 77.78% of the companies in the same industry.
86.11% of the companies in the same industry are more expensive than LFVN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.9
EV/EBITDA 7.51
LFVN Per share dataLFVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

LFVN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of LFVN may justify a higher PE ratio.
LFVN's earnings are expected to grow with 32.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y32.87%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.54%, LFVN has a reasonable but not impressive dividend return.
LFVN's Dividend Yield is a higher than the industry average which is at 5.51.
LFVN's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

LFVN has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LFVN Yearly Dividends per shareLFVN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

21.08% of the earnings are spent on dividend by LFVN. This is a low number and sustainable payout ratio.
DP21.08%
EPS Next 2Y32.87%
EPS Next 3YN/A
LFVN Yearly Income VS Free CF VS DividendLFVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
LFVN Dividend Payout.LFVN Dividend Payout, showing the Payout Ratio.LFVN Dividend Payout.PayoutRetained Earnings

LIFEVANTAGE CORP

NASDAQ:LFVN (9/15/2025, 8:13:30 PM)

After market: 10.68 0 (0%)

10.68

-0.45 (-4.04%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)09-04 2025-09-04/amc
Earnings (Next)10-27 2025-10-27
Inst Owners62.31%
Inst Owner Change17.25%
Ins Owners15.55%
Ins Owner Change0.9%
Market Cap135.53M
Analysts82.86
Price Target24.48 (129.21%)
Short Float %23.93%
Short Ratio18.07
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly Dividend0.55
Dividend Growth(5Y)N/A
DP21.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-08 2025-09-08 (0.045)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)25.47%
Min EPS beat(2)-5.12%
Max EPS beat(2)56.07%
EPS beat(4)2
Avg EPS beat(4)27.69%
Min EPS beat(4)-5.12%
Max EPS beat(4)61.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.55%
Min Revenue beat(2)-6.06%
Max Revenue beat(2)-5.04%
Revenue beat(4)0
Avg Revenue beat(4)-4.89%
Min Revenue beat(4)-7.05%
Max Revenue beat(4)-1.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)-19.05%
EPS NQ rev (3m)-19.05%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-7.91%
Revenue NQ rev (3m)-7.91%
Revenue NY rev (1m)-3.47%
Revenue NY rev (3m)-3.47%
Valuation
Industry RankSector Rank
PE 13.69
Fwd PE 10.42
P/S 0.59
P/FCF 12.9
P/OCF 11.41
P/B 3.91
P/tB 3.94
EV/EBITDA 7.51
EPS(TTM)0.78
EY7.3%
EPS(NY)1.03
Fwd EY9.6%
FCF(TTM)0.83
FCFY7.75%
OCF(TTM)0.94
OCFY8.76%
SpS18.01
BVpS2.73
TBVpS2.71
PEG (NY)0.44
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.63%
ROE 28.3%
ROCE 27.27%
ROIC 20.12%
ROICexc 36.69%
ROICexgc 37.06%
OM 5.34%
PM (TTM) 4.29%
GM 80.37%
FCFM 4.6%
ROA(3y)7.43%
ROA(5y)8.61%
ROE(3y)15.61%
ROE(5y)18.34%
ROIC(3y)11.79%
ROIC(5y)14.42%
ROICexc(3y)21.53%
ROICexc(5y)26%
ROICexgc(3y)21.81%
ROICexgc(5y)26.49%
ROCE(3y)15.97%
ROCE(5y)19.54%
ROICexcg growth 3Y16.93%
ROICexcg growth 5Y-18.84%
ROICexc growth 3Y17.48%
ROICexc growth 5Y-17.77%
OM growth 3Y13.18%
OM growth 5Y-4.32%
PM growth 3Y41.89%
PM growth 5Y-2.77%
GM growth 3Y-0.48%
GM growth 5Y-0.82%
F-Score8
Asset Turnover3.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 43.44%
Cap/Sales 0.6%
Interest Coverage 6099.5
Cash Conversion 77.36%
Profit Quality 107.16%
Current Ratio 1.87
Quick Ratio 1.11
Altman-Z 4.28
F-Score8
WACC8.7%
ROIC/WACC2.31
Cap/Depr(3y)63.96%
Cap/Depr(5y)69.38%
Cap/Sales(3y)1.05%
Cap/Sales(5y)1.12%
Profit Quality(3y)198.8%
Profit Quality(5y)180.19%
High Growth Momentum
Growth
EPS 1Y (TTM)34.48%
EPS 3Y23.91%
EPS 5Y-1.7%
EPS Q2Q%7.14%
EPS Next Y31.42%
EPS Next 2Y32.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.17%
Revenue growth 3Y3.45%
Revenue growth 5Y-0.38%
Sales Q2Q%12.64%
Revenue Next Year5.79%
Revenue Next 2Y2.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y181.54%
EBIT growth 3Y17.09%
EBIT growth 5Y-4.68%
EBIT Next Year104.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.58%
FCF growth 3Y17.78%
FCF growth 5Y-7.66%
OCF growth 1Y-2.62%
OCF growth 3Y14.27%
OCF growth 5Y-8.31%